Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

被引:253
|
作者
McMullen, Julie R. [1 ]
Amirahmadi, Fatemeh
Woodcock, Elizabeth A.
Schinke-Braun, Martina
Bouwman, Russell D.
Hewitt, Kimberly A.
Mollica, Janelle P.
Zhang, Li
Zhang, Yunyu
Shioi, Tetsuo
Buerger, Antje
Izumo, Seigo
Jay, Patrick Y.
Jennings, Garry L.
机构
[1] Baker Heart Res Inst, Expt Cardiol & Heart Failure Div, Melbourne, Vic 8008, Australia
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
[3] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[4] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
关键词
heart failure; signal transduction; heart growth; athlete's heart;
D O I
10.1073/pnas.0606663104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physical activity protects against cardiovascular disease, and physiological cardiac hypertrophy associated with regular exercise is usually beneficial, in marked contrast to pathological hypertrophy associated with disease. The p110 alpha isoform of phosphoinositide 3-kinase (PI3K) plays a critical role in the induction of exercise-induced hypertrophy. Whether it or other genes activated in the athlete's heart might have an impact on cardiac function and survival in a setting of heart failure is unknown. To examine whether progressive exercise training and PI3K(p110 alpha) activity affect survival and/or cardiac function in two models of heart disease, we subjected a transgenic mouse model of dilated cardiomyopathy (DCM) to swim training, genetically crossed cardiac-specific transgenic mice with increased or decreased PI3K(p110 alpha) activity to the DCM model, and subjected PI3K(p110 alpha) transgenics to acute pressure overload (ascending aortic constriction). Life span, cardiac function, and molecular markers of pathological hypertrophy were examined. Exercise training and increased cardiac PI3K(p110 alpha) activity prolonged survival in the DCM model by 15-20%. In contrast, reduced PI3K(p110 alpha) activity drastically shortened lifespan by approximate to 50%. Increased PI3K(p110 alpha) activity had a favorable effect on cardiac function and fibrosis in the pressure-overload model and attenuated pathological growth. PI3K(p110 alpha) signaling negatively regulated G protein-coupled receptor stimulated extracellular responsive kinase and Akt (via PI3K, p110 gamma) activation in isolated cardiomyocytes. These findings suggest that exercise and enhanced PI3K(p110 alpha) activity delay or prevent progression of heart disease, and that supraphysiologic activity can be beneficial. Identification of genes important for hypertrophy in the athlete's heart could offer new strategies for treating heart failure.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 50 条
  • [21] Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110δ
    Sawyer, C
    Sturge, J
    Bennett, DC
    O'Hare, MJ
    Allen, WE
    Bain, J
    Jones, GE
    Vanhaesebroeck, B
    CANCER RESEARCH, 2003, 63 (07) : 1667 - 1675
  • [22] Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex
    Jou, ST
    Carpino, N
    Takahashi, Y
    Piekorz, R
    Chao, JR
    Carpino, N
    Wang, DM
    Ihle, JN
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (24) : 8580 - 8591
  • [23] p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease
    Saudemont, Aurore
    Garcon, Fabien
    Yadi, Hakim
    Roche-Molina, Marta
    Kim, Nayoung
    Segonds-Pichon, Anne
    Martin-Fontecha, Alfonso
    Okkenhaug, Klaus
    Colucci, Francesco
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5795 - 5800
  • [24] Prognostic significance of phosphoinositide 3-kinase p110α and p110β isoforms in non-small cell lung cancer
    Lee, Ju Suk
    Lee, Hyoun Wook
    Lee, Eun Hee
    Park, Moon-Il
    Lee, Jae Seok
    Kim, Mee-Seon
    Kim, Seok-Hyun
    Kim, Tae Gyu
    Nam, Hyun-Yeol
    Hwang, Sang Won
    Park, Jae Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1554 - 1561
  • [25] Specific role of phosphoinositide 3-kinase p110α in the regulation of phagocytosis and pinocytosis in macrophages
    Tamura, Namiko
    Hazeki, Kaoru
    Okazaki, Natsumi
    Kametani, Yukiko
    Murakami, Hiroki
    Takaba, Yuki
    Ishikawa, Yuki
    Nigorikawa, Kiyomi
    Hazeki, Osamu
    BIOCHEMICAL JOURNAL, 2009, 423 : 99 - 108
  • [26] Genetic or pharmaceutical blockade of p110δ phosphoinositide 3-kinase enhances IgE production
    Zhang, Ting-ting
    Okkenhaug, Klaus
    Nashed, Baher F.
    Puri, Kamal D.
    Knight, Zachary A.
    Shokat, Kevan M.
    Vanhaesebroeck, Bart
    Marshall, Aaron J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (04) : 811 - 819
  • [27] Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
    Kang, S
    Denley, A
    Vanhaesebroeck, B
    Vogt, PK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1289 - 1294
  • [28] A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase
    Dbouk, Hashem A.
    Pang, Huan
    Fiser, Andras
    Backer, Jonathan M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) : 19897 - 19902
  • [29] Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
    Pretorius, Lynette
    Du, Xiao-Jun
    Woodcock, Elizabeth A.
    Kiriazis, Helen
    Lin, Ruby C. Y.
    Marasco, Silvana
    Medcalf, Robert L.
    Ming, Ziqiu
    Head, Geoffrey A.
    Tan, Joon Win
    Cemerlang, Nelly
    Sadoshima, Junichi
    Shioi, Tetsuo
    Izumo, Seigo
    Lukoshkova, Elena V.
    Dart, Anthony M.
    Jennings, Garry L.
    McMullen, Julie R.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (03): : 998 - 1009
  • [30] Expression of Phosphoinositide 3-Kinase p110 and p110 Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma
    Kim, Kyungeun
    Lee, Hyoun Wook
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (10) : 740 - 748